Gujarat Inject (Kerala) Ltd. Hits Upper Circuit for the 2nd Straight Session on BSE, 28 October 2026

Healthcare stocks are easy to bunch together, yet the Gujarat Inject (Kerala) upper circuit streak is about one counter alone: Gujarat Inject (Kerala) Ltd. was locked at Rs 11.19 on BSE on 28 October 2026, up 4.97% from the previous close of Rs 10.66, for a second straight session. The data contains no comparison with other pharmaceutical names, and none is drawn here.

The company’s market cap stands at Rs 156.16 crore, and the price was at the limit when this was written.

Key Takeaways

• Gujarat Inject (Kerala) Ltd. (GUJINJEC) hit the upper circuit on BSE at Rs 11.19 on 28 October 2026.
• The session move was +4.97% against a previous close of Rs 10.66.
• Market capitalisation stood at Rs 156.16 crore with a PE ratio of 52.17.
• This is the 2nd straight session at the upper circuit, with the run starting on 27 October 2026.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

All figures above are as of 28 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Gujarat Inject (Kerala) Ltd. opened on BSE at Rs 10.65, a shade under the previous close of Rs 10.66, and that opening print also marked the low of the session. Buyers then drove the price up until it reached Rs 11.19, which is both the high and the band price, and the stock stayed there.

The day’s gain is Rs 0.53, or 4.97%. All of these numbers come from BSE alone. A drug-sector peer listed on another exchange could carry a different band and previous close, so any sector comparison needs like-for-like figures that this note does not try to supply. The limit of Rs 11.19 is the level the price reached.

The Gujarat Inject (Kerala) Upper Circuit Streak So Far

This is session 2 of an unbroken run for Gujarat Inject (Kerala) Ltd. The streak began on 27 October 2026, from a base price of Rs 10.17. Across the run the stock has moved 10.03% in total.

A repeated upper circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.

This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.

Why Gujarat Inject (Kerala) Ltd. Hit Upper Circuit

Buying interest took Gujarat Inject (Kerala) Ltd. up to its exchange-defined price band, and the upper circuit held the price there at Rs 11.19. Company filings and outside news offered no verified reason for the day, so the sector is not credited with the move and price action and sentiment are all that can be read.

Earnings, corporate actions and rumours are likewise left out as explanations because none is confirmed. If a confirmed announcement appears, it would be added in a separate update.

Rs 11.19 was the upper circuit level in the session.

What the Gujarat Inject (Kerala) Upper Circuit Means

An upper circuit in one healthcare stock is no verdict on the pharmaceutical group. For Gujarat Inject (Kerala) Ltd. it means the price reached the highest level the band allowed, Rs 11.19 on 28 October 2026, and the observation stops at this one stock, with the band price set from the previous close of Rs 10.66.

Bands slow extreme swings and keep trading orderly. What a band records is the session itself. It forecasts no return, and it gives no information on how other names in the sector traded.

Gujarat Inject (Kerala) Ltd. Fundamentals and Valuation

The reported figures give more context than the price move alone. For Gujarat Inject (Kerala) Ltd. the record shows a PE ratio of 52.17, a PB ratio of 11.93, book value of Rs 0.89, EPS of 0.2 and a market cap of Rs 156.16 crore. None of it is a buy, sell or hold view.

Measured against book value of Rs 0.89, the price is a large multiple, which is what a PB ratio of 11.93 expresses, and the PE ratio of 52.17 rests on a very small EPS of 0.2. Premiums like these can reflect growth expectations, asset quality or limited trading in a smaller stock, and the ratios cannot say which. The company sits in the healthcare sector, in pharmaceuticals and drugs.

A second session at the band draws attention, but valuation, returns and the sector backdrop each need their own review before anything is concluded about the business.

Peer and Sector Context

Gujarat Inject (Kerala) Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Gujarat Inject (Kerala) Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Gujarat Inject (Kerala) Ltd.’s PE ratio was 52.17, compared with an available peer PE average of 64.76, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 61.96, the 50-day moving average was 9.66 and the 200-day moving average was 10.41.

What Readers Should Know

One fact stands confirmed: Gujarat Inject (Kerala) Ltd. was locked at the BSE band ceiling of Rs 11.19 on 28 October 2026, a rise of 4.97% and the second session in a row at the limit. Any link to the wider pharmaceutical group would need separate evidence.

In execution terms, buyers queue at the ceiling while sellers hold back, so the quoted price is not always one at which an order fills. Nothing official had been named as a catalyst by the time this note was prepared, which keeps the reading to price action alone.

Treat this as a market update. A locked price cannot replace separate checks of the business, its valuation, liquidity, risk and any confirmed company disclosures.

Frequently Asked Questions

Why did Gujarat Inject (Kerala) Ltd. hit upper circuit on 28 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

How many sessions has Gujarat Inject (Kerala) Ltd. hit upper circuit in a row?

This is session 2 of the current run, which began on 27 October 2026. This page is updated each session rather than replaced with a new article.

What was GUJINJEC share price on 28 October 2026?

The last traded price used in this article was Rs 11.19 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for GUJINJEC?

The upper circuit price was Rs 11.19. The stated exchange upper circuit limit was Rs 11.19. The event numbers in this article are aligned to BSE.

What is Gujarat Inject (Kerala) Ltd.’s market cap and PE ratio?

Gujarat Inject (Kerala) Ltd.’s market cap was Rs 156.16 crore. PE ratio was 52.17.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting an upper circuit mean Gujarat Inject (Kerala) Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Gujarat Inject (Kerala) Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Gujarat Inject (Kerala) Ltd. the stated limit was Rs 11.19. For this session, Gujarat Inject (Kerala) Ltd. moved 4.97%.